Cargando…

Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Detalles Bibliográficos
Autores principales: Ahmadizar, Fariba, Onland-Moret, N. Charlotte, de Boer, Anthonius, Liu, Geoffrey, Maitland-van der Zee, Anke H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619590/
https://www.ncbi.nlm.nih.gov/pubmed/26492353
http://dx.doi.org/10.1371/journal.pone.0141704
_version_ 1782397137714151424
author Ahmadizar, Fariba
Onland-Moret, N. Charlotte
de Boer, Anthonius
Liu, Geoffrey
Maitland-van der Zee, Anke H.
author_facet Ahmadizar, Fariba
Onland-Moret, N. Charlotte
de Boer, Anthonius
Liu, Geoffrey
Maitland-van der Zee, Anke H.
author_sort Ahmadizar, Fariba
collection PubMed
description
format Online
Article
Text
id pubmed-4619590
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46195902015-10-29 Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Ahmadizar, Fariba Onland-Moret, N. Charlotte de Boer, Anthonius Liu, Geoffrey Maitland-van der Zee, Anke H. PLoS One Correction Public Library of Science 2015-10-22 /pmc/articles/PMC4619590/ /pubmed/26492353 http://dx.doi.org/10.1371/journal.pone.0141704 Text en © 2015 Ahmadizar et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Ahmadizar, Fariba
Onland-Moret, N. Charlotte
de Boer, Anthonius
Liu, Geoffrey
Maitland-van der Zee, Anke H.
Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_full Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_fullStr Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_full_unstemmed Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_short Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
title_sort correction: efficacy and safety assessment of the addition of bevacizumab to adjuvant therapy agents in cancer patients: a systematic review and meta-analysis of randomized controlled trials
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619590/
https://www.ncbi.nlm.nih.gov/pubmed/26492353
http://dx.doi.org/10.1371/journal.pone.0141704
work_keys_str_mv AT ahmadizarfariba correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT onlandmoretncharlotte correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT deboeranthonius correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT liugeoffrey correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT maitlandvanderzeeankeh correctionefficacyandsafetyassessmentoftheadditionofbevacizumabtoadjuvanttherapyagentsincancerpatientsasystematicreviewandmetaanalysisofrandomizedcontrolledtrials